Investigating how structural racism affects dementia risk in different communities.
Multilevel Forms of Structural Racism and Racial Inequalities in ADRD Risk
This study is looking at how structural racism might increase the risk of Alzheimer’s Disease and related dementias in Black adults, with the goal of finding ways to reduce these risks and improve health outcomes for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11059148 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between structural racism and the risk of developing Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD), particularly among Black adults who are disproportionately affected. The study aims to identify early risk factors and explore how public health interventions can mitigate these risks. By employing longitudinal studies and causal modeling techniques, the research seeks to uncover the long-term impacts of structural racism on health inequalities related to dementia. Patients may benefit from insights that could lead to targeted interventions and policies aimed at reducing these disparities.
Who could benefit from this research
Good fit: Ideal candidates for participation include Black adults and individuals from communities affected by structural racism who are at risk for AD/ADRD.
Not a fit: Patients who do not identify as part of the affected racial or ethnic groups or those without risk factors for dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved public health strategies that reduce the risk of dementia among vulnerable populations.
How similar studies have performed: Previous research has shown that addressing social determinants of health can lead to improved outcomes in various health conditions, suggesting potential for success in this area.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Martin, Chantel L. — Univ of North Carolina Chapel Hill
- Study coordinator: Martin, Chantel L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.